Lung Cancer Europe’s Post

On World Health Day, it's crucial to raise awareness about cancer, responsible for nearly one in six deaths. Due to the growing crisis among younger generations, by 2030, early-onset cancer diagnoses are projected to surge by 30%. ⚠️Certain cancers, such as colorectal and gastrointestinal types, are showing particularly steep increases among young adults. Even traditionally, age-associated cancers, like lung cancer, are affecting younger, non-smoking women more frequently. Early detection is critical, as 90% of cases detected early have significantly increased chances of survival. At Oncoliq🧬, we are developing a method for early cancer detection using a small blood sample. You can read more here 👉 https://lnkd.in/d6XuXuGM #WorldHealthDay #EarlyDetection #Oncoliq

The Bowel Cancer Screening age has decreased to 45. People aged 40-44 (previously 45-49) are also able to request screening via their healthcare professional. Recent Australian research has shown that self-advocating is the only consistent and reliable resource for overcoming age bias, barriers to diagnosis, and optimising outcomes for a disease that is not only on the rise, but the deadliest cancer for those aged 25-44. Visit the Bowel Cancer Australia website to learn more about why the screening age has been lowered from 50 to 45, and why it’s important to know that if you have symptoms, you’re never too young to get screened. https://lnkd.in/gkeCrSQ3

𝐃𝐢𝐝 𝐲𝐨𝐮 𝐤𝐧𝐨𝐰? Every day, countless lives are lost globally due to cancer. In 2019, over 3 million individuals worldwide received a diagnosis of lung cancer, marking the highest mortality rate among cancers. Additionally, in 2020, nearly 2.3 million women faced a diagnosis of breast cancer, ranking it as the second most fatal cancer globally. Statistics from 2018 to 2023 reveal a consistent pattern of annual incidence and mortality rates for lung and breast cancers, the two most prevalent forms of cancer worldwide. While genetics and environmental factors contribute to 30% of cancer cases, up to 70% of cancers can be prevented by adopting a healthy diet. Given the significant global impact of cancer, let's prioritize prevention efforts to create a cancer-free environment. Ref : WHO Yearly Report, NCBI, American Cancer Society Journals #EFILife #LiveLifeTruly #LifeInsurance #Cancer #knowledge

"I attributed my bloating to a strong course of antibiotics I’d just finished. My gynecologist thought the same thing—until she discovered a hard spot when she pressed down on my belly during a well-woman exam." -Angela Hernandez, University of Texas MD Anderson Cancer Care Center Angela’s experience underscores the vague nature of some ovarian cancer symptoms, which can often be attributed to less serious conditions. Alarmingly, 1 out of every 87 women will be diagnosed with ovarian cancer in their lifetime, but only about 20% are diagnosed at early stage. To help address the need for tools and resources to improve quality care, the Association of Cancer Care Centers (ACCC) initiated a comprehensive effort to enhance ovarian cancer care in the US. Key areas identified include: • Genetic testing and counseling • Clinical trial enrollment • Coordinated care across multidisciplinary teams Read more and share this ongoing project for the improvement of quality of care for patients with ovarian cancer at https://bit.ly/4b6nQ5J. The full blog article is available at https://bit.ly/4b6o78L #WorldOvarianCancerDay #OvarianCancerAwareness #WomensHealth

Day 6 of Head & Neck Cancer Awareness Month and AYA Cancer Awareness Week According to the NIH SEER database, between 2000-2020 the incidence of tongue cancer has risen in the US AYA population (age 15-39) with an APC of 1.1% for males and 1.3% for females. If we go back to 1975 -- the APC is 1.3% for males and 1.9% for females. Additionally, the 5-year relative survival rate (data calculated between 2013-2019) in the same age group drops drastically from 88.7% in those diagnosed in the early, localized stage of disease to 56.8% in those diagnosed with regional metastasis. Roughly 50% of AYAs tongue cancers are diagnosed in an early stage. I know we make up a very small amount (<0.1%) of the total US population, but we matter. We are some of your future decision makers, creators, healers, and gamechangers. How do we prove our lives are worth saving? How do we prove our quality of life is important? How do we calculate the invisible -- the human potential lost? #headandneckcancer #tonguecancer #ayacancer #survivorship #cancerawareness

💡 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄? 𝗕𝗹𝗮𝗱𝗱𝗲𝗿 𝗰𝗮𝗻𝗰𝗲𝗿 𝗶𝘀 𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗳𝗲𝘄 𝗰𝗮𝗻𝗰𝗲𝗿𝘀 𝘄𝗵𝗲𝗿𝗲 𝘄𝗼𝗺𝗲𝗻 𝗮𝗿𝗲 𝗼𝗳𝘁𝗲𝗻 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗲𝗱 𝗮𝘁 𝗮 𝗹𝗮𝘁𝗲𝗿 𝘀𝘁𝗮𝗴𝗲 𝘁𝗵𝗮𝗻 𝗺𝗲𝗻, 𝗶𝗺𝗽𝗮𝗰𝘁𝗶𝗻𝗴 𝘀𝘂𝗿𝘃𝗶𝘃𝗮𝗹 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀.   Bladder cancer affects men more frequently, with over 2,000 new invasive cases each year compared to over 500 in women. Yet, despite the lower incidence, women face unique challenges. Approximately 𝟱𝟴% 𝗼𝗳 𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗰𝗮𝗻𝗰𝗲𝗿𝘀 𝗶𝗻 𝘄𝗼𝗺𝗲𝗻 𝗮𝗿𝗲 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗺𝘂𝘀𝗰𝗹𝗲-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 (𝗶.𝗲. 𝗮𝘁 𝗹𝗲𝗮𝘀𝘁 𝘀𝘁𝗮𝗴𝗲 𝗜𝗜) 𝗮𝘁 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲 𝗼𝗳 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 — compared to 𝟰𝟰% 𝗶𝗻 𝗺𝗲𝗻. This delay in detection leads to more advanced cancer in women and impacts outcomes, as men currently see a higher 5-year net survival rate of 𝟲𝟭% versus 𝟱𝟮% for women.   These statistics highlight the need for continued awareness and research. Greater understanding can empower earlier intervention, leading to better outcomes for all affected by bladder cancer.   For more information, see our 𝗖𝗮𝗻𝗰𝗲𝗿 𝗙𝗮𝗰𝘁 𝗦𝗵𝗲𝗲𝘁: https://lnkd.in/eypEnApw.   #CancerFactThursday #BladderCancer #CancerAwareness #CancerRegistration

#lungcancer #cancerresearch #oncology https://lnkd.in/g3UtnXnx Abstract Background: Despite the various #anticancer activities of #tocopherols, little is known about tocopherols associated with lung cancer risk among low-income African Americans (AA) and European Americans (EA) who are disproportionately affected by the disease. Methods: We conducted a nested case–control study that included 209 incident lung cancer cases and 406 matched controls within the Southern Community Cohort Study. Using biospecimens collected at cohort enrollment, plasma levels of α-, β/γ-, δ-, and total-tocopherols were measured by high-performance liquid chromatography with photodiode array detection. Conditional logistic regression was used to estimate ORs and 95% confidence intervals (CI) for lung cancer risk after adjusting for potential confounders. Stratified analyses were also conducted. Conclusions: Our results indicate that plasma total-tocopherols are inversely associated with lung cancer risk, but the association may differ across specific isomeric forms of tocopherols, race, or other individuals’ characteristics. Further large-scale studies are warranted to confirm our findings. Impact: Recommendations on tocopherols for lung cancer prevention should take isomers, race, and smoking behaviors into consideration.

Fantastic to meet with Minister Andrew Gwynne to talk through cancer services and how we can work in partnership to prioritise patients, alongside colleagues at Macmillan Cancer Support and Cancer Research UK (CRUK).   As outlined in Cancer52’s manifesto for rare and less common cancers our three key priorities for Government are: 1️⃣  Reduce the number of deaths from all cancers by 15% by 2040, saving 80,000 lives, and address health inequalities that contribute to poorer outcomes.  2️⃣  Increase early diagnosis of rare and less common cancers, which will improve patient experience, quality of life and help save more lives.  3️⃣  A new national mission on rare and less common cancers with patient involvement at its core. 

There have been many scientific advances in the diagnosis and treatment of lung cancer, yet it is Europe’s leading cause of cancer-related mortality, and so great need remains to accelerate progress for those affected by this disease. Recently we partnered with The Health Policy Partnership to do just that – convening leading lung cancer experts and advocates across Europe to discuss where we can identify opportunities to improve survival. Early detection, targeted innovative treatments and care are key opportunities to improve patient outcomes and survival. By working together with the lung cancer community, we can find solutions that truly make a difference.   Catch up on the conversation below! #LungCancer #InFrontOfCancer #MyCompany

🫁 November is Lung Cancer Awareness Month 🫁 This month, let’s come together to shed light on one of the world’s most common – yet preventable – cancers. #LungCancer claims more lives than any other cancer, but #awareness, #EarlyDetection, and #LifestyleChanges can make a tremendous difference. Early symptoms can be subtle, making regular screenings critical, especially for those at higher risk. Advances in diagnostics, like low-dose CT scans and innovative biomarker panels, are helping detect lung cancer earlier when treatment is most effective. Let’s honor this month by: 1. Encouraging loved ones to get screened if they're at risk 2. Supporting research and innovation in early detection 3. Spreading awareness of lifestyle choices that lower risk Together, we can fight for early detection, treatment breakthroughs, and, ultimately, a future free from lung cancer. #LungCancerAwareness #EarlyDetection #LungHealth #HealthMatters #AwarenessSavesLives